Email ID
Password
Sign me in automatically next time
Scrip Regulatory Affairs
EU's medtech industry criticises fragmented approach to innovation
29 January 2010
Vibha Sharma

The European Commission, in its exploratory process on the future of medical devices, has revealed a consensus among stakeholders that there is a need to develop new tools and mechanisms to evaluate the impact of innovation on the sector1,2.

In its final report on the process that lists potential themes for future reflection, the commission talks about the “shared vision” of participants on the need to consider the “concept of innovation” in a broader sense...

Please login to read the full article.
 
 
 
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
   
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36